Understanding physician-pharmaceutical industry interactions

New York: Cambridge University Press (2007)
  Copy   BIBTEX


Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain ignorant of the core issues and are ill-prepared to understand pharmaceutical industry promotion. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry



    Upload a copy of this work     Papers currently archived: 92,873

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library


Added to PP

35 (#468,757)

6 months
5 (#702,332)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Disease-mongering through clinical trials.María González-Moreno, Cristian Saborido & David Teira - 2015 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 51:11-18.
Attitudes of Future Doctors of Bangladesh to Pharmaceutical Incentives and Medical Ethics.Tonmoy Biswas & Darryl Macer - 2017 - Eubios Journal of Asian and International Bioethics 27 (3):70-80.

Add more citations

References found in this work

No references found.

Add more references